Morphological and Histopathological Study of Autopsied Patients with Atherosclerosis and HIV

Page: [121 - 127] Pages: 7

  • * (Excluding Mailing and Handling)

Abstract

Background: Chronic infection by HIV evolves with a vascular inflammatory action causing endothelial dysfunction. The action of the virus, as well as the side effects of antiretroviral drugs, contribute to the progression of cardiovascular diseases. The present study aimed to evaluate the percentage of collagen fibers and the density of mast cells, chymase and tryptase, in aortas of patients with and without HIV, and also patients with and without atherosclerosis.

Methods: Aortic fragments were obtained from autopsied patients aged 22-69 years and selected regardless of the cause of death or underlying disease. The samples were divided into four groups, (1) Group with HIV and with atherosclerosis; (2) Group with HIV and without atherosclerosis; (3) Group without HIV and with atherosclerosis; (4) Group without HIV and without atherosclerosis (Control). The percentage of collagen fibers was analyzed in the intima-media layer and the density of mast cells was analyzed in all aortic layers. Graphpad Prism 5.0® software was used for statistical analysis.

Results: There were more collagen fibers in HIV patients, with or without atherosclerosis. The group with HIV and atherosclerosis presented a higher density of chymase and tryptase mast cells. The correlation between collagen fibers and age was negative in the non-HIV group and with atherosclerosis.

Conclusion: The inflammatory process resulting from HIV infection may be relevant in the alteration of aortic collagen fibers and in triggering or accelerating atherosclerosis. The study is important because HIV patients have increased risks for the development of cardiovascular diseases, and follow-up is necessary to prevent such diseases.

Keywords: Aorta, cardiovascular diseases, collagen, HIV, atherosclerosis, mast cells.

Graphical Abstract

[1]
CDC. Estimated HIV incidence and prevalence in the United States, HIV Surveillance Supplemental Report 2020.
[2]
UNAIDS. Joint United Nations Programme on HIV/AIDS. The life-cycle approach to HIV Finding solutions for everyone at every stage of life 2016.
[3]
Triant VA, Lee H, Hadigan C, Grinspoon SK. Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. J Clin Endocrinol Metab 2007; 92(7): 2506-12.
[http://dx.doi.org/10.1210/jc.2006-2190] [PMID: 17456578]
[4]
Dubé MP, Lipshultz SE, Fichtenbaum CJ, Greenberg R, Schecter AD, Fisher SD. Working Group 3. Effects of HIV infection and antiretroviral therapy on the heart and vasculature. Circulation 2008; 118(2): e36-40.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.107.189625] [PMID: 18566318]
[5]
Palella FJ Jr, Phair JP. Cardiovascular disease in HIV infection. Curr Opin HIV AIDS 2011; 6(4): 266-71.
[http://dx.doi.org/10.1097/COH.0b013e328347876c] [PMID: 21546831]
[6]
Klein D, Leyden WA, Xu L, et al. Contribution of immunodeficiency to CHD: cohort study of HIV+ and HIV– Kaiser Permanente members. Eighteenth Conference on Retroviruses and Opportunistic Infections. Boston. 2011.
[7]
Monteiro VS, Lacerda HR, Uellendah M, et al. Escore de cálcio na avaliação da aterosclerose em pacientes com HIV/AIDS. Arq Bras Cardiol 2011; 97(5): 427-33.
[http://dx.doi.org/10.1590/S0066-782X2011005000094] [PMID: 21971633]
[8]
Hansson GK. Atherosclerosis--an immune disease: The Anitschkov Lecture 2007. Atherosclerosis 2009; 202(1): 2-10.
[http://dx.doi.org/10.1016/j.atherosclerosis.2008.08.039] [PMID: 18951547]
[9]
Bot I, de Jager SC, Zernecke A, et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 2007; 115(19): 2516-25.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.106.660472] [PMID: 17470698]
[10]
Strong JP, McGILL HC Jr. The natural history of coronary atherosclerosis. Am J Pathol 1962; 40: 37-49.
[PMID: 13917861]
[11]
Stalioraityte E, Pangonyte D, Simanaitis M. [Trends in the development of atherosclerosis in Kaunas population]. Medicina (Kaunas) 2002; 38(3): 333-42.
[PMID: 12474707]
[12]
Ramalho LS, Oliveira LF, Cavellani CL, et al. Role of mast cell chymase and tryptase in the progression of atherosclerosis: study in 44 autopsied cases. Ann Diagn Pathol 2013; 17(1): 28-31.
[http://dx.doi.org/10.1016/j.anndiagpath.2012.04.007] [PMID: 22658852]
[13]
Ferraz MLF, Nascimento DMS, Rorato JPH, et al. Correlation of lifetime progress of atherosclerosis and morphologic markers of severity in humans: new tools for a more sensitive evaluation. Clinics 2012; 67: 1071.
[http://dx.doi.org/10.6061/clinics/2012(09)15]
[14]
Steinsvoll S. HELGELAND K., SCHENCK K. Mast cells – a role in periodontal disease? J Clin Periodontol 2004; (31): 413-9.
[http://dx.doi.org/10.1111/j.1600-051X.2004.00516.x] [PMID: 15142208]
[15]
Walsh LJ. Mast cells and oral inflammation. Crit Rev Oral Biol Med 2003; 14(3): 188-98.
[http://dx.doi.org/10.1177/154411130301400304] [PMID: 12799322]
[16]
Gruber BL, Schwartz LB, Ramamurthy NS, Irani AM, Marchese MJ. Activation of latent rheumatoid synovial collagenase by human mast cell tryptase. J Immunol 1988; 140(11): 3936-42.
[PMID: 2453561]
[17]
Takai S, Jin D, Muramatsu M, Miyazaki M. Chymase as a novel target for the prevention of vascular diseases. Trends Pharmacol Sci 2004; 25(10): 518-22.
[http://dx.doi.org/10.1016/j.tips.2004.08.007] [PMID: 15380935]
[18]
Williams MA. Quantitative Methods in Biology. North Holland 1977. Vol. 6, pp. 234.
[19]
Junqueira LCU, Bignolas G, Brentani RR. A simple and sensitive method for the quantitative estimation of collagen. Anal Biochem 1979; 94: 96.
[http://dx.doi.org/10.1016/0003-2697(79)90795-4]
[20]
Davis PH, Dawson JD, Blecha MB, Mastbergen RK, Sonka M. Measurement of aortic intimal-medial thickness in adolescents and young adults. Ultrasound Med Biol 2010; 36(4): 560-5.
[http://dx.doi.org/10.1016/j.ultrasmedbio.2010.01.002] [PMID: 20350682]
[21]
Reddy S, Kumar P, Prasad K. Histomorphometric and sympathetic innervation of the human internal thoracic artery. Clinics (São Paulo) 2011; 66(1): 131-6.
[http://dx.doi.org/10.1590/S1807-59322011000100023] [PMID: 21437449]
[22]
Di Biagio A, Del Bono V, Rosso R, Viscoli C. HIV and accelerated atheroprogression: role of antiretroviral therapy. Curr Pharm Biotechnol 2012; 13(1): 88-96.
[http://dx.doi.org/10.2174/138920112798868520] [PMID: 21470158]
[23]
Manduteanu I, Simionescu M. Inflammation in atherosclerosis: a cause or a result of vascular disorders? J Cell Mol Med 2012; 16(9): 1978-90.
[http://dx.doi.org/10.1111/j.1582-4934.2012.01552.x] [PMID: 22348535]
[24]
De Lorenzo F, Collot-Teixeira S, Boffito M, Feher M, Gazzard B, McGregor JL. Metabolic-inflammatory changes, and accelerated atherosclerosis in HIV patients: rationale for preventative measures. Curr Med Chem 2008; 15(28): 2991-9.
[http://dx.doi.org/10.2174/092986708786848668] [PMID: 19075647]
[25]
Mercié P, Thiébaut R, Lavignolle V, et al. Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement. Ann Med 2002; 34(1): 55-63.
[http://dx.doi.org/10.1080/078538902317338652] [PMID: 12014436]
[26]
Kearns AC, Liu F, Dai S, et al. Caspase-1 activation is related with HIV-associated atherosclerosis in a HIV transgenic mouse model and HIV patient cohort. Arterioscler Thromb Vasc Biol 2019; 39(9): 1762-75.
[http://dx.doi.org/10.1161/ATVBAHA.119.312603] [PMID: 31315440]
[27]
Althoff KN, Gange SJ. A critical epidemiological review of cardiovascular disease risk in HIV-infected adults: the importance of the HIV-uninfected comparison group, confounding, and competing risks. HIV Med 2013; 14(3): 191-2.
[http://dx.doi.org/10.1111/hiv.12007] [PMID: 23368691]
[28]
Islam FM, Wu J, Jansson J, Wilson DP. Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis. HIV Med 2012; 13(8): 453-68.
[http://dx.doi.org/10.1111/j.1468-1293.2012.00996.x] [PMID: 22413967]
[29]
Subramanian S, Tawakol A, Burdo TH, et al. Arterial inflammation in patients with HIV. JAMA 2012; 308(4): 379-86.
[http://dx.doi.org/10.1001/jama.2012.6698] [PMID: 22820791]
[30]
Tessitore E, Rundek T, Jin Z, Homma S, Sacco RL, Di Tullio MR. Association between carotid intima-media thickness and aortic arch plaques. J Am Soc Echocardiogr 2010; 23(7): 772-7.
[http://dx.doi.org/10.1016/j.echo.2010.04.012] [PMID: 20510582]
[31]
Ortiz-Velázquez RI, Caldas JG, Lobo BC, Santos-Franco JA, Mercado-Pimentel R, Revuelta R. Effects of the modification of the aortic bifurcation geometry: a technical note regarding a novel model for experimental atherosclerotic and aneurysmatic lesions. Clinics (São Paulo) 2010; 65(3): 345-6.
[http://dx.doi.org/10.1590/S1807-59322010000300018] [PMID: 20360929]
[32]
Bampi AB, Rochitte CE, Favarato D, Lemos PA, da Luz PL. Comparison of non-invasive methods for the detection of coronary atherosclerosis. Clinics (São Paulo) 2009; 64(7): 675-82.
[http://dx.doi.org/10.1590/S1807-59322009000700012] [PMID: 19606245]
[33]
Odink AE, van der Lugt A, Hofman A, et al. Risk factors for coronary, aortic arch and carotid calcification; The Rotterdam Study. J Hum Hypertens 2010; 24(2): 86-92.
[http://dx.doi.org/10.1038/jhh.2009.42] [PMID: 19494836]
[34]
Adiguzel E, Ahmad PJ, Franco C, Bendeck MP. Collagens in the progression and complications of atherosclerosis. Vasc Med 2009; 14(1): 73-89.
[http://dx.doi.org/10.1177/1358863X08094801] [PMID: 19144782]
[35]
Heikkilä HM, Lätti S, Leskinen MJ, Hakala JK, Kovanen PT, Lindstedt KA. Activated mast cells induce endothelial cell apoptosis by a combined action of chymase and tumor necrosis factor-α. Arterioscler Thromb Vasc Biol 2008; 28(2): 309-14.
[http://dx.doi.org/10.1161/ATVBAHA.107.151340] [PMID: 18079408]
[36]
Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007; 115(4): 459-67.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.106.628875] [PMID: 17242284]
[37]
Zarins CK, Xu C, Glagov S. Atherosclerotic enlargement of the human abdominal aorta. Atherosclerosis 2001; 155(1): 157-64.
[http://dx.doi.org/10.1016/S0021-9150(00)00527-X] [PMID: 11223437]
[38]
Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions oftherosclerosis, A report from the committee on vascular lesions of the council on atherosclerosis. American Heart Association. Circulation 1994; 89(5): 2462-78.
[http://dx.doi.org/10.1161/01.CIR.89.5.2462] [PMID: 8181179]
[39]
Stoof TJ, Mitra RS, Sarma V, Dixit VM, Nickoloff BJ. Keratinocyte activation following T-lymphocyte binding. J Invest Dermatol 1992; 98(1): 92-5.
[http://dx.doi.org/10.1111/1523-1747.ep12495676] [PMID: 1345824]
[40]
Peshkova IO, Schaefer G, Koltsova EK. Atherosclerosis and aortic aneurysmeis inflammation a common denominator? FEBS J 2016; 283: 1636.
[41]
Astrand H, Stalhand J, Karlsson J, Karlsson M, Sonesson B, Länne T. In vivo estimation of the contribution of elastin and collagen to the mechanical properties in the human abdominal aorta: effect of age and sex. J Appl Physiol (1985) 2011; 110(1): 176-87.
[http://dx.doi.org/10.1152/japplphysiol.00579.2010] [PMID: 21071586]
[42]
Coimbra DD, et al. Colagenoma eruptivo em paciente HIV+.Rio de Janeiro. An Bras Dermatol 2008; 83(2)
[http://dx.doi.org/10.1590/S0365-05962008000200007]
[43]
Nakashima Y, Fujii H, Sumiyoshi S, Wight TN, Sueishi K. Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol 2007; 27(5): 1159-65.
[http://dx.doi.org/10.1161/ATVBAHA.106.134080] [PMID: 17303781]
[44]
Lindstedt KA, Mäyränpää MI, Kovanen PT. Mast cells in vulnerable atherosclerotic plaques--a view to a kill. J Cell Mol Med 2007; 11(4): 739-58.
[http://dx.doi.org/10.1111/j.1582-4934.2007.00052.x] [PMID: 17760836]
[45]
Nakamura Y, Suzuki T, Miki Y, et al. Estrogen receptors in atherosclerotic human aorta: inhibition of human vascular smooth muscle cell proliferation by estrogens. Mol Cell Endocrinol 2004; 219(1-2): 17-26.
[http://dx.doi.org/10.1016/j.mce.2004.02.013] [PMID: 15149723]
[46]
Jeziorska M, McCollum C, Woolley DE. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J Pathol 1997; 182(1): 115-22.
[http://dx.doi.org/10.1002/(SICI)1096-9896(199705)182:1<115::AID-PATH806>3.0.CO;2-9] [PMID: 9227350]
[47]
Kaartinen M, Penttila A, Kovanen PT. Demonstration of tryptase- and tryptase/chymase-containing mast cells in normal intimas, fatty streaks, and the shoulder region of atheromas. . Mast cells of two types differing in neutral protease composition in the human aortic intima. Arteriosclerosis and thrombosis : a journal of vascular biology/American Heart Association 1994; 14(6): 966-72.
[48]
de Lima Pereira SA, dos Santos VM, Rodrigues DB, da Cunha Castro EC, dos Reis MA, de Paula Antunes Teixeira V. Quantitative analysis of fibrosis and mast cells in the tongue of chronic chagasic patients: autopsy study. Med Mal Infect 2007; 37(4): 229-33.
[http://dx.doi.org/10.1016/j.medmal.2006.11.013] [PMID: 17346914]
[49]
Sun J, Sukhova GK, Wolters PJ, et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 2007; 13(6): 719-24.
[http://dx.doi.org/10.1038/nm1601] [PMID: 17546038]
[50]
Baumruker T, Csonga R, Pursch E, Pfeffer A, Urtz N, Sutton S, et al. Activation of mast cells by incorporation of cholesterol into rafts: Journal international. Immunology 2003; 5(10): 1207-18.
[51]
Kelesidis T, Yang OO, Kendall MA, Hodis HN, Currier JS. Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults. Lipids Health Dis 2013; 12: 23.
[http://dx.doi.org/10.1186/1476-511X-12-23] [PMID: 23510548]
[52]
BonamigoTP. Tratamento cirúrgico dos aneurismas da aorta abdominal: existe diferença nos resultados entre homens e mulheres? J Vasc Bras 2006; 2: 101.
[53]
Rasheed S, Yan JS, Lau A, Chan AS. HIV replication enhances production of free fatty acids, low density lipoproteins and many key proteins involved in lipid metabolism: a proteomics study. PLoS One 2008; 3(8): e3003.
[http://dx.doi.org/10.1371/journal.pone.0003003] [PMID: 18714345]
[54]
Van Craeyveld E, Gordts SC, Singh N, Jacobs F, De Geest B. A critical reassessment of murine and rabbit models of atherosclerosis: focus on lesion progression and remodelling. Acta Cardiol 2012; 67(1): 11-21.
[http://dx.doi.org/10.1080/AC.67.1.2146561] [PMID: 22455085]
[55]
Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res 2005; 66(2): 286-94.
[http://dx.doi.org/10.1016/j.cardiores.2004.12.027] [PMID: 15820197]
[56]
Fisher GJ, Kang S, Varani J, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002; 138(11): 1462-70.
[http://dx.doi.org/10.1001/archderm.138.11.1462] [PMID: 12437452]
[57]
Atkinson JB, Harlan CW, Harlan GC, Virmani R. The association of mast cells and atherosclerosis: a morphologic study of early atherosclerotic lesions in young people. Hum Pathol 1994; 25(2): 154-9.
[http://dx.doi.org/10.1016/0046-8177(94)90271-2] [PMID: 7726878]
[58]
Ignotz RA, Massague´ J. Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986; 261: 4337.
[59]
Morton LF, Barnes MJ. Collagen polymorphism in the normal and diseased blood vessel wall: Investigation of collagens types I, III and V. 1982; 42: 41-51.
[60]
Costantino S, Paneni F, Cosentino F. Ageing, metabolism and cardiovascular disease. J Physiol 2016; 594(8): 2061-73.
[http://dx.doi.org/10.1113/JP270538] [PMID: 26391109]
[61]
Stratton JR, Levy WC, Caldwell JH, et al. Effects of aging on cardiovascular responses to parasympathetic withdrawal. J Am Coll Cardiol 2003; 41(11): 2077-83.
[http://dx.doi.org/10.1016/S0735-1097(03)00418-2] [PMID: 12798585]
[62]
Casella IB, Sotelo FJ, Yamazaki Y, Presti C, Vassoler A, Melo HA. Comparison of common carotid artery intima-media thickness between Brazilian Euro-descendants and Afro-descendants with atherosclerosis risk factors. Clinics (São Paulo) 2009; 64(7): 657-64.
[http://dx.doi.org/10.1590/S1807-59322009000700009] [PMID: 19606242]
[63]
Nakashima Y, Chen YX, Kinukawa N, Sueishi K. Distributions of diffuse intimal thickening in human arteries: preferential expression in atherosclerosis-prone arteries from an early age. Virchows Archiv: an international journal of pathology 2002; 441(3): 279-88.
[http://dx.doi.org/10.1007/s00428-002-0605-1]
[64]
Chung JH, Seo JY, Choi HR, et al. Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J Invest Dermatol 2001; 117(5): 1218-24.
[http://dx.doi.org/10.1046/j.0022-202x.2001.01544.x] [PMID: 11710936]